{"id":"https://openalex.org/W1991735339","doi":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","title":"Analysis of Binding Sites for the New Small-Molecule CCR5 Antagonist TAK-220 on Human CCR5","display_name":"Analysis of Binding Sites for the New Small-Molecule CCR5 Antagonist TAK-220 on Human CCR5","publication_year":2005,"publication_date":"2005-10-26","ids":{"openalex":"https://openalex.org/W1991735339","doi":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","mag":"1991735339","pmid":"https://pubmed.ncbi.nlm.nih.gov/16251315","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1280122"},"language":"en","primary_location":{"id":"doi:10.1128/aac.49.11.4708-4715.2005","doi":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC1280122","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Masao Nishikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masao Nishikawa","raw_affiliation_strings":["Department of Microbiology, Kansai Medical University, Osaka 570-8506"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Kansai Medical University, Osaka 570-8506","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088292988","display_name":"Katsunori Takashima","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Katsunori Takashima","raw_affiliation_strings":["Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022398836","display_name":"Toshiya Nishi","orcid":"https://orcid.org/0000-0002-9451-2423","observed_orcids":["https://orcid.org/0000-0002-9451-2423"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiya Nishi","raw_affiliation_strings":["Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028434992","display_name":"Rika A. Furuta","orcid":"https://orcid.org/0000-0002-7962-8954","observed_orcids":["https://orcid.org/0000-0002-7962-8954"]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Rika A. Furuta","raw_affiliation_strings":["Department of Microbiology, Kansai Medical University, Osaka 570-8506"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Kansai Medical University, Osaka 570-8506","institution_ids":["https://openalex.org/I126884977"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090477990","display_name":"Naoyuki Kanzaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Naoyuki Kanzaki","raw_affiliation_strings":["Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044627041","display_name":"Yoshio Yamamoto","orcid":"https://orcid.org/0000-0002-6352-6013","observed_orcids":["https://orcid.org/0000-0002-6352-6013"]},"institutions":[{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshio Yamamoto","raw_affiliation_strings":["Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Research Division, Takeda Pharmaceutical Company, Ltd., Osaka 532-8686, Japan","institution_ids":["https://openalex.org/I44892455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101789814","display_name":"Jun\u2013ichi Fujisawa","orcid":"https://orcid.org/0000-0003-0775-5580","observed_orcids":["https://orcid.org/0000-0003-0775-5580"]},"institutions":[{"id":"https://openalex.org/I126884977","display_name":"Kansai Medical University","ror":"https://ror.org/001xjdh50","country_code":"JP","type":"education","lineage":["https://openalex.org/I126884977"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Jun-ichi Fujisawa","raw_affiliation_strings":["Department of Microbiology, Kansai Medical University, Osaka 570-8506"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Microbiology, Kansai Medical University, Osaka 570-8506","institution_ids":["https://openalex.org/I126884977"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5101789814"],"corresponding_institution_ids":["https://openalex.org/I126884977"],"apc_list":null,"apc_paid":null,"fwci":4.4798,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.94862737,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"49","issue":"11","first_page":"4708","last_page":"4715"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11532","display_name":"Chemokine receptors and signaling","score":0.7035999894142151,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.12999999523162842,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0714000016450882,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr5","display_name":"CCR5","score":0.9129999876022339},{"id":"https://openalex.org/keywords/ccr5-antagonist","display_name":"CCR5 antagonist","score":0.7710000276565552},{"id":"https://openalex.org/keywords/hiv-1-coreceptor","display_name":"HIV-1 coreceptor","score":0.8690000176429749},{"id":"https://openalex.org/keywords/binding-sites","display_name":"binding sites","score":0.5619999766349792},{"id":"https://openalex.org/keywords/transmembrane-domain","display_name":"transmembrane domain","score":0.8690000176429749},{"id":"https://openalex.org/keywords/tak-779","display_name":"TAK-779","score":0.9480000138282776},{"id":"https://openalex.org/keywords/amino-acid-residues","display_name":"amino acid residues","score":0.48399999737739563},{"id":"https://openalex.org/keywords/drug-receptor-interactions","display_name":"drug-receptor interactions","score":0.5550000071525574},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C37044404","wikidata":"https://www.wikidata.org/wiki/Q5009692","display_name":"CCR5 receptor antagonist","level":5,"score":0.8837990760803223},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.670250654220581},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.660271406173706},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5309816002845764},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.5198017358779907},{"id":"https://openalex.org/C143065580","wikidata":"https://www.wikidata.org/wiki/Q3285695","display_name":"Mutant","level":3,"score":0.501917839050293},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.4940055012702942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.483679860830307},{"id":"https://openalex.org/C118892022","wikidata":"https://www.wikidata.org/wiki/Q7834587","display_name":"Transmembrane domain","level":3,"score":0.46317583322525024},{"id":"https://openalex.org/C51639874","wikidata":"https://www.wikidata.org/wiki/Q167149","display_name":"Plasma protein binding","level":2,"score":0.4323425889015198},{"id":"https://openalex.org/C2777339483","wikidata":"https://www.wikidata.org/wiki/Q647203","display_name":"Conformational change","level":2,"score":0.4233567714691162},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.4217830002307892},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3677256107330322},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.34390896558761597},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.27936920523643494},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.21118876338005066},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.1295468509197235},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.12320694327354431}],"mesh":[{"descriptor_ui":"D000577","descriptor_name":"Amides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000595","descriptor_name":"Amino Acid Sequence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000644","descriptor_name":"Quaternary Ammonium Compounds","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008969","descriptor_name":"Molecular Sequence Data","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010880","descriptor_name":"Piperidines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019713","descriptor_name":"Receptors, CCR5","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019713","descriptor_name":"Receptors, CCR5","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D065100","descriptor_name":"CCR5 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.49.11.4708-4715.2005","doi":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.49.11.4708-4715.2005","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:204676","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1280122","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:16251315","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16251315","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1280122","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC1280122/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:204676","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC1280122","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"score":0.8999999761581421,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":53,"referenced_works":["https://openalex.org/W82820957","https://openalex.org/W166507259","https://openalex.org/W1494346716","https://openalex.org/W1562621350","https://openalex.org/W1568479508","https://openalex.org/W1642524132","https://openalex.org/W1965019797","https://openalex.org/W1965485473","https://openalex.org/W1965508366","https://openalex.org/W1981164507","https://openalex.org/W1981440980","https://openalex.org/W1981644527","https://openalex.org/W1996024432","https://openalex.org/W1996183144","https://openalex.org/W1998817729","https://openalex.org/W2005980845","https://openalex.org/W2010521915","https://openalex.org/W2013238066","https://openalex.org/W2027812093","https://openalex.org/W2032020323","https://openalex.org/W2033757712","https://openalex.org/W2034430377","https://openalex.org/W2044004371","https://openalex.org/W2046999368","https://openalex.org/W2058252938","https://openalex.org/W2067933523","https://openalex.org/W2071381113","https://openalex.org/W2072482781","https://openalex.org/W2081071886","https://openalex.org/W2089138872","https://openalex.org/W2106882534","https://openalex.org/W2107696483","https://openalex.org/W2107973727","https://openalex.org/W2113282092","https://openalex.org/W2130479394","https://openalex.org/W2131376910","https://openalex.org/W2131859684","https://openalex.org/W2137493643","https://openalex.org/W2138758139","https://openalex.org/W2140478082","https://openalex.org/W2143312620","https://openalex.org/W2147169218","https://openalex.org/W2154205595","https://openalex.org/W2161911309","https://openalex.org/W2163611230","https://openalex.org/W2166080054","https://openalex.org/W2170412417","https://openalex.org/W2241071176","https://openalex.org/W2397879788","https://openalex.org/W2412710840","https://openalex.org/W4211151736","https://openalex.org/W4234857678","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2096965774","https://openalex.org/W1974089699","https://openalex.org/W2460815319","https://openalex.org/W2005980845","https://openalex.org/W2044004371","https://openalex.org/W4234681086","https://openalex.org/W2027288034","https://openalex.org/W2107973727","https://openalex.org/W2152815720","https://openalex.org/W2021008862"],"abstract_inverted_index":{"G":[0],"protein-coupled":[1],"receptor":[2],"CCR5":[3,19,34,79,89,179,188],"is":[4],"the":[5,57,60,64,93,109,133,136,140,164,178],"main":[6],"coreceptor":[7],"for":[8,121],"macrophage-tropic":[9],"human":[10,78],"immunodeficiency":[11],"virus":[12,67],"type":[13],"1":[14],"(HIV-1),":[15],"and":[16,52,80,100,113,118,138,157],"various":[17],"small-molecule":[18,187],"antagonists":[20],"are":[21],"being":[22],"developed":[23],"to":[24,39,161,183],"treat":[25],"HIV-1":[26],"infection.":[27],"It":[28],"has":[29],"been":[30],"reported":[31],"that":[32,86],"such":[33],"antagonists,":[35],"including":[36],"TAK-779,":[37],"bind":[38],"a":[40,73,87,185],"putative":[41,94],"binding":[42,167],"pocket":[43],"formed":[44],"by":[45],"transmembrane":[46],"domains":[47],"(TMs)":[48],"1,":[49],"2,":[50],"3":[51],"7":[53],"of":[54,59,63,132,143,172,177],"CCR5,":[55,139],"indicating":[56],"importance":[58],"conformational":[61],"changes":[62],"TMs":[65,116,154],"during":[66],"entry.":[68],"In":[69],"this":[70],"report,":[71],"using":[72],"single-round":[74],"infection":[75],"assay":[76],"with":[77,104,129,149,174],"its":[81,122],"substitution":[82],"mutants,":[83],"we":[84],"demonstrated":[85],"new":[88,186],"antagonist,":[90],"TAK-220,":[91],"shares":[92],"interacting":[95],"amino":[96,150],"acid":[97,151],"residues":[98,111,152],"Asn252":[99],"Leu255":[101],"in":[102,115,153,159,163],"TM6":[103],"TAK-779":[105],"but":[106],"also":[107],"requires":[108],"distinct":[110],"Gly163":[112],"Ile198":[114],"4":[117],"5,":[119,156],"respectively,":[120],"inhibitory":[123,141],"effect.":[124],"We":[125],"suggested":[126],"that,":[127],"together":[128],"molecular":[130],"models":[131],"interactions":[134,148],"between":[135],"drugs":[137,173],"activity":[142],"TAK-220":[144],"could":[145],"involve":[146],"direct":[147],"4,":[155],"6":[158],"addition":[160],"those":[162],"previously":[165],"postulated":[166],"pocket.":[168],"The":[169],"possible":[170],"interaction":[171],"additional":[175],"regions":[176],"molecule":[180],"would":[181],"help":[182],"develop":[184],"antagonist.":[189]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}